Mohamed Elshaikh
University of Michigan
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mohamed Elshaikh.
Lancet Oncology | 2005
Jean M. Moran; Mohamed Elshaikh; Theodore S. Lawrence
The specialty of radiotherapy has changed rapidly over the past two decades with the development of more sophisticated planning and delivery techniques. These techniques have made it possible to increase safely the radiation dose to the tumour while limiting the dose to surrounding healthy tissues that are sensitive to radiation. Here, we focus on clinical improvements that have been achieved with technological advances in the planning and delivery of radiotherapy and look at the potential for future improvements. It should be noted that improved understanding of the biology underlying the radiation response and the use of chemotherapy and molecularly targeted therapy to enhance radiation sensitivity have contributed equally to the improved outcome of patients undergoing radiotherapy.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2007
Aaron M. Allen; Mohamed Elshaikh; Francis P. Worden; Carol R. Bradford; Theodoros N. Teknos; Douglas B. Chepeha; Christina Tsien; Laura A Dawson; Susan G. Urba; Gregory T. Wolf; Daniel P. Normolle; Avraham Eisbruch
Our aim was to evaluate the acceleration of a hyperfractionated, concurrent chemoradiation regimen (HxCRT) for advanced head and neck squamous cell carcinoma (HNSCC).
Archive | 2006
Mohamed Elshaikh; Roger M. Macklis
Radiation therapy is an important modality in the management of both primary and metastatic tumors involving the spine and spinal cord. The mesenchymal elements of the spinal column and its contents may give rise to a wide variety of primary tumors. Yet, primary neoplastic lesions of the spine are rare, accounting for roughly 5 to 10% of all skeletal tumors. Metastatic lesions of the spine are far more common (1). True spinal cord neoplasms are relatively rare and typically intradural in location. Radiation therapy has evolved over the past decades to better meet these needs. Better pretreatment imaging studies, megavoltage linear accelerators, and computer-based three-dimentional (3D) treatment planning are all improving radiation dose distributions, thus, decreasing the likelihood of severe acute or late toxicity.
International Journal of Radiation Oncology Biology Physics | 2007
Michael J. Zelefsky; Deborah A. Kuban; Larry B. Levy; Louis Potters; David C. Beyer; John C. Blasko; Brian J. Moran; Jay P. Ciezki; Anthony L. Zietman; Thomas M. Pisansky; Mohamed Elshaikh; Eric M. Horwitz
International Journal of Radiation Oncology Biology Physics | 2005
Siavash Jabbari; Hyungjin Myra Kim; Mary Feng; Alexander Lin; Christina Tsien; Mohamed Elshaikh; Jeffrey E. Terrel; Carol Anne Murdoch-Kinch; Avraham Eisbruch
International Journal of Radiation Oncology Biology Physics | 2005
Deborah A. Kuban; Larry B. Levy; Louis Potters; David C. Beyer; John C. Blasko; Brian J. Moran; Jay P. Ciezki; Anthony L. Zietman; Michael J. Zelefsky; Thomas M. Pisansky; Mohamed Elshaikh; Eric M. Horwitz
Annual Review of Medicine | 2006
Mohamed Elshaikh; Mats Ljungman; Randall K. Ten Haken; Allen S. Lichter
Archive | 2005
Mohamed Elshaikh; James Ulchaker; C.A. Reddy; Kenneth W. Angermeier; Eric A. Klein; Nabil Chehade; Andrew Altman; Jay P. Ciezki
International Journal of Radiation Oncology Biology Physics | 2005
Michael J. Zelefsky; Deborah A. Kuban; Lawrence B. Levy; Louis Potters; David C. Beyer; J.C. Blasko; Brian J. Moran; Jay P. Ciezki; Anthony L. Zietman; Thomas M. Pisansky; Mohamed Elshaikh; Eric M. Horwitz
International Journal of Radiation Oncology Biology Physics | 2006
Daniel E. Soto; Irwin H. Lee; R. Roberts; Charlie Pan; Mohamed Elshaikh; Michael E. Ray; Patrick W. McLaughlin; Howard M. Sandler